OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Machine learning, pharmacogenomics, and clinical psychiatry: predicting antidepressant response in patients with major depressive disorder
William V. Bobo, Bailey Van Ommeren, Arjun P. Athreya
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 8, pp. 927-944
Closed Access | Times Cited: 14

Showing 14 citing articles:

Integrative toxicogenomics: Advancing precision medicine and toxicology through artificial intelligence and OMICs technology
Ajay Vikram Singh, Vaisali Chandrasekar, Namuna Paudel, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114784-114784
Open Access | Times Cited: 83

Artificial Intelligence and Neuroscience: Transformative Synergies in Brain Research and Clinical Applications
Răzvan Onciul, Cătălina-Ioana Tătaru, Adrian Dumitru, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 550-550
Open Access | Times Cited: 3

Demographic and clinical predictors of response and remission in the treatment of major depressive disorder with ketamine and esketamine: A systematic review
Juliana Lima Constantino, Michael Godschalk, Jens H. van Dalfsen, et al.
Psychiatry Research (2025) Vol. 345, pp. 116355-116355
Open Access | Times Cited: 1

Inteligencia artificial en medicina: presente y futuro
Dioselina Lanzagorta-Ortega, Diego Luis Carrillo‐Pérez, Raúl Carrillo-Esper
Gaceta Médica de México (2022) Vol. 158, Iss. 91
Open Access | Times Cited: 32

The emergence, implementation, and future growth of pharmacogenomics in psychiatry: a narrative review
Chad A. Bousman, Abdullah Al Maruf, Diogo Marques, et al.
Psychological Medicine (2023) Vol. 53, Iss. 16, pp. 7983-7993
Open Access | Times Cited: 19

Targeted Research and Treatment Implications in Women With Depression
Marie E. Gaine, Kathleen M. Jagodnik, Ritika Baweja, et al.
FOCUS The Journal of Lifelong Learning in Psychiatry (2025) Vol. 23, Iss. 2, pp. 141-155
Closed Access

Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm?
Anthi Maslarinou, Vangelis G. Manolopoulos, Georgia Ragia
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10

Pharmacomicrobiomics of Antidepressants in Depression: A Systematic Review
Lisa Brown, William V. Bobo, Cory A. Gall, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 7, pp. 1086-1086
Open Access | Times Cited: 9

Artificial intelligence, medications, pharmacogenomics, and ethics
Susanne B. Haga
Pharmacogenomics (2024), pp. 1-12
Closed Access | Times Cited: 2

Artificial intelligence in the detection and treatment of depressive disorders: a narrative review of literature
Fabiana Ricci, Daniela Giallanella, Costanza Gaggiano, et al.
International Review of Psychiatry (2024), pp. 1-13
Closed Access

Initial Evaluation of a Personalized Advantage Index to Determine Which Individuals May Benefit from Mindfulness-Based Cognitive Therapy for Suicide Prevention
Catherine E. Myers, Chintan Dave, Megan S. Chesin, et al.
Behaviour Research and Therapy (2024) Vol. 183, pp. 104637-104637
Closed Access

Artificial intelligence ecosystem for computational psychiatry: Ideas to practice
Xinqiao Liu, Xinyu Ji, Xing Weng, et al.
World Journal of Meta-Analysis (2023) Vol. 11, Iss. 4, pp. 79-91
Open Access | Times Cited: 1

La evidencia científica de las consecuencias de la modernidad
Miguel Cruz
Gaceta Médica de México (2022) Vol. 158, Iss. 91
Open Access

Page 1

Scroll to top